Study protocol for a randomised controlled feasibility trial of a virtual intervention (STRIDE) for symptom management, distress and adherence to adjuvant endocrine therapy after breast cancer.

ABSTRACT:

Introduction

Patient adherence to adjuvant endocrine therapy (AET) after a diagnosis of hormone-sensitive breast cancer is poor. Previous interventions have failed to produce changes in adherence, address patient preferences or include theoretically informed and evidence-based components. Therefore, we iteratively developed a patient-centred, evidence-based, small-group, videoconference intervention to improve adherence and symptom management as well as reduce distress for patients taking AET after breast cancer (Symptom-Targeted Randomised Intervention for Distress and Adherence to Adjuvant Endocrine Therapy, STRIDE).

Methods and analysis

The current study is a non-blinded, randomised, controlled, feasibility trial of STRIDE compared with a medication monitoring control gro

SUBMITTER: Jacobs JM 

PROVIDER: S-EPMC7783524 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature